|  Help  |  About  |  Contact Us

Publication : Fine-tuned cholesterol solubilizer, mono-6-O-α-D-maltosyl-γ-cyclodextrin, ameliorates experimental Niemann-Pick disease type C without hearing loss.

First Author  Yamada Y Year  2022
Journal  Biomed Pharmacother Volume  155
Pages  113698 PubMed ID  36116252
Mgi Jnum  J:329991 Mgi Id  MGI:7355805
Doi  10.1016/j.biopha.2022.113698 Citation  Yamada Y, et al. (2022) Fine-tuned cholesterol solubilizer, mono-6-O-alpha-D-maltosyl-gamma-cyclodextrin, ameliorates experimental Niemann-Pick disease type C without hearing loss. Biomed Pharmacother 155:113698
abstractText  Niemann-Pick disease type C (NPC) is a fatal disorder with abnormal intracellular cholesterol trafficking resulting in neurodegeneration and hepatosplenomegaly. A cyclic heptasaccharide with different degrees of substitution of 2-hydroxypropyl groups, 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD), acts as a strong cholesterol solubilizer and is under investigation for treating this disease in clinical trials, but its physicochemical properties and ototoxicity remain a concern. Here, we evaluated the potential of mono-6-O-alpha-maltosyl-gamma-CD (G2-gamma-CD), a single-maltose-branched cyclic octasaccharide with a larger cavity than HP-beta-CD, for treating NPC. We identified that G2-gamma-CD ameliorated NPC manifestations in model mice and showed lower ototoxicity in mice than HP-beta-CD. To investigate the molecular mechanisms of action behind the differential ototoxicity of these CDs, we performed cholesterol solubility analysis, proton nuclear magnetic resonance spectroscopy, and molecular modeling, and estimated that the cholesterol inclusion mode of G2-gamma-CD maintained solely the 1:1 inclusion complex, whereas that of HP-beta-CD shifted to the highly-soluble 2:1 complex at higher concentrations. We predicted the associations of these differential complexations of CDs with cholesterol with the profile of disease attenuation and of the auditory cell toxicity using specific cell models. We proposed that G2-gamma-CD can serve as a fine-tuned cholesterol solubilizer for treating NPC, being highly biocompatible and physicochemically suitable for clinical application.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression